Jaan-Olle Andressoo

RSS-feed av denna lista

  1. GDNF CONTROLS URETER LENGTH BY REGULATING COLLECTING DUCT PROGENITOR EXPANSION

    Li, H., Jakobson, M., Ola, R., Sariola, H., Andressoo, J. & Kuure, S. sep 2017 I : Pediatric Nephrology. 32, 9, s. 1651-1651 1 s.

    Forskningsoutput: Forskning - Peer reviewMötesabstrakt

  2. Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine

    Kopra, J., Villarta-Aguilera, M., Savolainen, M., Weingerl, S., Myohänen, T. T., Rannanpää, S., Salvatore, M. E., Andressoo, J-O. & Piepponen, T. P. jan 2018 I : Neuropharmacology. 128, s. 221-230 10 s.

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  3. Dampened Amphetamine-Stimulated Behavior and Altered Dopamine Transporter Function in the Absence of Brain GDNF

    Kopra, J. J., Panhelainen, A., af Bjerken, S., Porokuokka, L. L., Varendi, K., Olfat, S., Montonen, H., Piepponen, T. P., Saarma, M. & Andressoo, J-O. 8 feb 2017 I : Journal of Neuroscience. 37, 6, s. 1581-1590 10 s.

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  4. Biology of GDNF and its receptors - Relevance for disorders of the central nervous system

    Ibanez, C. F. & Andressoo, J-O. jan 2017 I : Neurobiology of Disease. 97, part B, s. 80-89 10 s.

    Forskningsoutput: Vetenskaplig - Peer reviewÖversiktsartikel

  5. GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function

    Kumar, A., Kopra, J. J., Varendi, K., Porokuokka, L. L., Panhelainen, A. E., Kuure, S. H., Marshall, P. O. L., Karalija, N., Härma, M-A., Vilenius, C. L., Lilleväli, K., Tekko, T., Mijatovic, J., Pulkkinen, N., Jakobson, M., Jakobson, M., Ola, R., Palm, E., Lindahl, M. S., Strömberg, I., Võikar, V., Piepponen, T. P., Saarma, M. & Andressoo, J-O. 2015 I : PLoS Genetics. 11, 12, 24 s., e1005710

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  6. From microRNA target validation to therapy: lessons learned from studies on BDNF

    Varendi, K., Mätlik, K. & Andressoo, J-O. maj 2015 I : Cellular and Molecular Life Sciences. 72, 9, s. 1779-1794 16 s.

    Forskningsoutput: Vetenskaplig - Peer reviewÖversiktsartikel

  7. GDNF is not required for catecholaminergic neuron survival in vivo

    Kopra, J., Vilenius, C., Grealish, S., Härma, M-A., Varendi, K., Lindholm, J., Castrén, E., Voikar, V., Björklund, A., Piepponen, T. P., Saarma, M. & Andressoo, J-O. mar 2015 I : Nature Neuroscience. 18, 3, s. 319-322 4 s.

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  8. Tristetraprolin is a novel regulator of BDNF.

    Kumar, A., Varendi, K., Peränen, J. & Andressoo, J-O. 2014 I : SpringerPlus. 3, 10 s., 502

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  9. miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF

    Varendi, K., Kumar, A., Härmä, M-A. & Andressoo, J-O. 2014 I : Cellular and Molecular Life Sciences. 71, 22, s. 4443-4456 14 s.

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  10. Short-term Preoperative Dietary Restriction Is Neuroprotective in a Rat Focal Stroke Model

    Varendi, K., Airavaara, M., Anttila, J., Vose, S., Planken, A., Saarma, M., Mitchell, J. R. & Andressoo, J-O. 4 apr 2014 I : PLoS One. 9, 4, 9 s., 93911

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

Föregående 1 2 3 4 Nästa